Corrigendum to "Management of endometriosis-related infertility: Considerations and treatment options".
Corrigendum to "Management of endometriosis-related infertility: Considerations and treatment options". Clin Exp Reprod Med. 2020 Apr 08;: Authors: Lee D, Kim SK, Lee JR, Jee BC PMID: 32259915 [PubMed - as supplied by publisher]
ConclusionsAlthough no human studies have been performed so far, the cell and animal model study results suggest that LXA4 will be used in obstetrics and gynecology soon.
Publication date: Available online 27 May 2020Source: Reproductive BioMedicine OnlineAuthor(s): G. Anupa, Jeevitha Poorasamy, Muzaffer A Bhat, Jai Bhagwan Sharma, Jayasree Sengupta, Debabrata Ghosh
Endometriosis is an oestrogen-dependent disease. The problem of this disease concerns about 10% of fertile and 30-50% of infertile women [1 –3]. No specific marker for endometriosis has yet been identified. The latest studies indicate a correlation between genetic polymorphisms and the risk of endometriosis [4–9].
The objective was to evaluate the quality of life and the incidence of depression among women suffering from endometriosis. Afterwards, the dependency between pelvic pain, its severity and stages of endometriosis were analyzed. The study protocol included women of reproductive ages with confirmed endometriosis. The stage of disease was conferred according to the ASRM (American Society of Reproductive Medicine) classification. Women fulfilled two questionnaires: “WERF EPHect Clinical Questionnaire” and self-prepared survey about fertility disorders. The study group comprised of 246 respondents. A total o...
Authors: Pejovic T, Thisted S, White M, Nezhat FR Abstract Endometriosis is a gynecologic disease that affects over 10% of women of reproductive age causing pelvic pain, dysmenorrhea, and infertility, resulting in significant disability and reduced quality of life. Very recent genetic studies have suggested that endometriosis is a clonal disease in the epithelium and its development is independent of stroma, providing new insight into the genesis of endometriosis. The endometrioid tissue lining may also react by epithelial atypical hyperplasia and even neoplasia, in a manner somehow similar to that in the uterine c...
Authors: Rowe H, Quinlivan J PMID: 32400301 [PubMed - in process]
AbstractEndometriosis is a common benign gynecological condition defined as the presence of endometrial tissue located outside the uterus and frequently associated with chronic pelvic pain and infertility. It is a polymorphic disease that can be presented as superficial implants, endometriomas and deep lesions that infiltrate the peritoneal surface associated with fibrosis and inflammatory reaction. Diagnosis of deep endometriosis is difficult and delayed, frequently missed in a routine ultrasound. Transvaginal ultrasound is the first-line imaging modality to investigate endometriosis and when performed by an expert in fem...
ConclusionAs patients increasingly utilize social media to obtain and engage with health information, it is critical to understand the fertility-related SM landscape. This understanding may help to successfully enhance relationships with patients and ensure dissemination of accurate information.
Despite intense research, the pathophysiological mechanisms of premature ovarian aging, leading to reduced ovarian reserve and possibly infertility in young women, are still poorly understood. Well-established risks for reduced ovarian reserve are aggressive ovarian surgery, endometriosis and cytotoxic therapy; however, gene mutations such as the Fragile X syndrome can also cause premature follicle loss and a reduced ovarian reserve.
Subspecialty inherently focuses clinicians on outcomes related to their expertise. With reproductive endocrinology and infertility (REI) increasingly focusing on the “I” and that “I” often standing more for in vitro fertilization (IVF) than just infertility, it is tempting to look at gynecologic and other comorbidities primarily in how they affect IVF outcomes. In the quest for the highest live birth rate per cycle, broader patient wellness shouldn’t be lost. One of the founders of Johns Hopkins Hospital, Sir William Osler, said, “The good physician treats the disease.